Future Pharmacology

MDPI AG

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Future Pharmacology is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2673-9879
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,000 CHF
Articles in DOAJ
242
Declared review time
6 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2022-11-20
Indexing
DOAJ
APC
1,000 CHF
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

242

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

263

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

19

i10-index

42

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2023-04-12
Added to DOAJ
2022-11-20
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
99%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Pharmacogenetics and Drug Metabolism
  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Pharmacogenetics and Drug Metabolism
Show all subjects (50)
  • Synthesis and biological activity
  • Nanoparticle-Based Drug Delivery
  • Advanced Drug Delivery Systems
  • Synthesis and biological activity
  • Nanoparticle-Based Drug Delivery
  • Phytochemicals and Antioxidant Activities
  • Pharmacological Effects and Toxicity Studies
  • Phytochemicals and Antioxidant Activities
  • Advanced Drug Delivery Systems
  • Pharmacological Effects and Toxicity Studies
  • Receptor Mechanisms and Signaling
  • Drug Transport and Resistance Mechanisms
  • Tryptophan and brain disorders
  • Curcumin's Biomedical Applications
  • Curcumin's Biomedical Applications
  • Receptor Mechanisms and Signaling
  • Drug Transport and Resistance Mechanisms
  • Cancer therapeutics and mechanisms
  • Cancer, Stress, Anesthesia, and Immune Response
  • Cancer therapeutics and mechanisms
  • Antimicrobial Peptides and Activities
  • Cannabis and Cannabinoid Research
  • Cannabis and Cannabinoid Research
  • Cancer, Stress, Anesthesia, and Immune Response
  • Antimicrobial Peptides and Activities
  • Tryptophan and brain disorders
  • Nanoplatforms for cancer theranostics
  • Acute Lymphoblastic Leukemia research
  • Antibiotics Pharmacokinetics and Efficacy
  • Inflammatory mediators and NSAID effects
  • SARS-CoV-2 and COVID-19 Research
  • Advancements in Transdermal Drug Delivery
  • Neurotransmitter Receptor Influence on Behavior
  • Advancements in Transdermal Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Acute Lymphoblastic Leukemia research
  • Inflammatory mediators and NSAID effects
  • Wound Healing and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Phytochemistry and Biological Activities
  • Neurotransmitter Receptor Influence on Behavior
  • Forensic Toxicology and Drug Analysis

Keywords (DOAJ)

  • drug design and discovery
  • clinical pharmacology
  • cellular pharmacology
  • neuropharmacology
  • drug misuse and addiction
  • biopharmaceuticals

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: